Literature DB >> 11728742

Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.

C Giroud1, A Ménétrey, M Augsburger, T Buclin, P Sanchez-Mazas, P Mangin.   

Abstract

The recreational use and abuse of Cannabis is continuously increasing in Switzerland. Cannabinoids are very often detected alone or in combination with other drugs in biological samples taken from drivers suspected of driving under the influence of drugs. Moreover, they are also frequently found in blood specimens from people involved in various medico-legal events, e.g. muggings, murders, rapes and working accidents as well. In order to assess the influence of Cannabis exposure on man behavior and performances, it is often needed to estimate the time of Cannabis use. For that purpose two mathematical models have been set up by Huestis and coworkers. These models are based on cannabinoids concentrations in plasma. Because plasma samples are rarely available for forensic determinations in our laboratory, it could be useful to assess the time-laps since Cannabis use through these models from whole blood values. One prerequisite to the use of these models from whole blood values is the knowledge of the plasma to whole blood concentrations distribution ratios of cannabinoids. In this respect, the Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH concentrations were measured in plasma and whole blood taken from eight volunteers who smoke Cannabis on a regular basis. Cannabinoids levels were also determined in "serum" and whole blood samples taken from six corpses. The values of the plasma to whole blood distribution ratios were found to be very similar and their individual coefficient of variation relatively low suggesting that plasma levels could be calculated from whole blood concentrations taken into account a multiplying factor of 1.6. The data obtained postmortem suggest that the distribution of cannabinoids between whole blood and "serum" is scattered over a larger range of values than those determined from living people and that more cannabinoids (mean value of the serum/whole blood concentrations ratios=2.4) can be recovered from the "serum" fraction. The successful use of the mathematical models of Huestis and coworkers may, therefore, rely in part upon the selection of the appropriate blood sample, i.e. plasma. When plasma is not available, whole blood values could be considered with some caution taken into account a multiplying factor of 1.6 to calculate plasma concentrations from blood values. In the case of blood samples taken after death, the use of these models to assess the time of Cannabis use is not recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728742     DOI: 10.1016/s0379-0738(01)00538-2

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  11 in total

1.  Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).

Authors:  Michael G Holland; David M Schwope; Robert Stoppacher; Shane B Gillen; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2011-07-20       Impact factor: 2.395

2.  Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Authors:  Marianne Hädener; Tim J Gelmi; Marie Martin-Fabritius; Wolfgang Weinmann; Matthias Pfäffli
Journal:  Int J Legal Med       Date:  2019-01-05       Impact factor: 2.686

3.  Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.

Authors:  Erin L Karschner; Madeleine J Swortwood; Jussi Hirvonen; Robert S Goodwin; Wendy M Bosker; Johannes G Ramaekers; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-06-11       Impact factor: 3.345

4.  Characterizing and Quantifying Extrahepatic Metabolism of (-)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC).

Authors:  Aditya R Kumar; Gabriela I Patilea-Vrana; Olena Anoshchenko; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2022-04-03       Impact factor: 3.579

5.  Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing.

Authors:  Eugene W Schwilke; Erin L Karschner; Ross H Lowe; Ann M Gordon; Jean Lud Cadet; Ronald I Herning; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-03-05       Impact factor: 8.327

6.  Development and Verification of a Linked Δ 9-THC/11-OH-THC Physiologically Based Pharmacokinetic Model in Healthy, Nonpregnant Population and Extrapolation to Pregnant Women.

Authors:  Gabriela I Patilea-Vrana; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2021-05-05       Impact factor: 3.579

7.  Prevalence of alcohol and drug use in injured British Columbia drivers.

Authors:  Jeffrey R Brubacher; Herbert Chan; Walter Martz; William Schreiber; Mark Asbridge; Jeffrey Eppler; Adam Lund; Scott Macdonald; Olaf Drummer; Roy Purssell; Gary Andolfatto; Robert Mann; Rollin Brant
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

8.  Pediatric Death Due to Myocarditis After Exposure to Cannabis.

Authors:  Thomas M Nappe; Christopher O Hoyte
Journal:  Clin Pract Cases Emerg Med       Date:  2017-03-16

9.  Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving.

Authors:  Giovanni Battistella; Eleonora Fornari; Aurélien Thomas; Jean-Frédéric Mall; Haithem Chtioui; Monique Appenzeller; Jean-Marie Annoni; Bernard Favrat; Philippe Maeder; Christian Giroud
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

10.  Enzymatic digestion and selective quantification of underivatised delta-9-tetrahydrocannabinol and cocaine in human hair using gas chromatography-mass spectrometry.

Authors:  Salah Eddine Breidi; James Barker; Andrea Petróczi; Declan P Naughton
Journal:  J Anal Methods Chem       Date:  2012-04-03       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.